Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Perioperative Sedation in Pudendal Neuralgia With Anxiety
ChiCTR2500106316Phase 4Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in pudendal neuralgia (PN) and anxiety disorder (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Perioperative anxiety visual analog scale. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
pudendal neuralgia (PN)anxiety disorder
Beyond the preview
Go deeper on ChiCTR2500106316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106316.